Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer
6213.0000 101.00 (1.65%)
NSE Sep 19, 2025 13:36 PM
Volume: 472.3K
 

6213.00
1.65%
SMC online
The growth was driven across generic APIs and CRAMS businesses. Strong positioning of divis will help in monetizing the growth opportunity in API and CRAMS space given its stellar execution track record and being one of the preferred suppliers. Further, recently done and...
Number of FII/FPI investors increased from 922 to 990 in Jun 2025 qtr.
More from Divi's Laboratories Ltd.
Recommended